HEADER TRANSFERASE 05-SEP-13 4C4I TITLE STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE TITLE 2 INHIBITORS OF THE MITOTIC KINASE MPS1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 519-808; COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT, COMPND 6 MONOPOLAR SPINDLE KINASE 1; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI KEYWDS TRANSFERASE, MITOSIS, STRUCTURE-BASED DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR S.NAUD,I.M.WESTWOOD,A.FAISAL,P.SHELDRAKE,V.BAVETSIAS,B.ATRASH,M.LIU, AUTHOR 2 A.HAYES,J.SCHMITT,A.WOOD,V.CHOI,K.BOXALL,G.MAK,M.GURDEN,M.VALENTI, AUTHOR 3 A.DE HAVEN BRANDON,A.HENLEY,R.BAKER,C.MCANDREW,B.MATIJSSEN,R.BURKE, AUTHOR 4 S.A.ECCLES,F.I.RAYNAUD,S.LINARDOPOULOS,R.VAN MONTFORT,J.BLAGG REVDAT 3 20-DEC-23 4C4I 1 REMARK REVDAT 2 15-JAN-14 4C4I 1 JRNL REVDAT 1 04-DEC-13 4C4I 0 JRNL AUTH S.NAUD,I.M.WESTWOOD,A.FAISAL,P.W.SHELDRAKE,V.BAVETSIAS, JRNL AUTH 2 B.ATRASH,K.J.CHEUNG,M.LIU,A.HAYES,J.SCHMITT,A.WOOD,V.CHOI, JRNL AUTH 3 K.BOXALL,G.MAK,M.GURDEN,M.VALENTI,A.DE-HAVEN-BRANDON, JRNL AUTH 4 A.HENLEY,R.BAKER,C.MCANDREW,B.MATIJSSEN,R.BURKE,S.HOELDER, JRNL AUTH 5 S.A.ECCLES,F.I.RAYNAUD,S.LINARDOPOULOS,R.L.M.VAN MONTFORT, JRNL AUTH 6 J.BLAGG JRNL TITL STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE 1H-PYRROLO[3, JRNL TITL 2 2-C]PYRIDINE INHIBITORS OF THE MITOTIC KINASE MONOPOLAR JRNL TITL 3 SPINDLE 1 (MPS1). JRNL REF J.MED.CHEM. V. 56 10045 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24256217 JRNL DOI 10.1021/JM401395S REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 12233 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 594 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.28 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2861 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2220 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2726 REMARK 3 BIN R VALUE (WORKING SET) : 0.2204 REMARK 3 BIN FREE R VALUE : 0.2538 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.72 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1964 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 1 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 89.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 83.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.20340 REMARK 3 B22 (A**2) : -16.51880 REMARK 3 B33 (A**2) : 2.31540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.385 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.339 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.224 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.350 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2052 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2797 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 675 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 320 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2052 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 277 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2293 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.84 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.46 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|516 - A|596 } REMARK 3 ORIGIN FOR THE GROUP (A): -9.1234 -23.0702 -14.8212 REMARK 3 T TENSOR REMARK 3 T11: 0.2460 T22: 0.4520 REMARK 3 T33: 0.2061 T12: -0.0258 REMARK 3 T13: -0.0149 T23: -0.0822 REMARK 3 L TENSOR REMARK 3 L11: 7.7968 L22: 2.1261 REMARK 3 L33: 6.2852 L12: 0.7983 REMARK 3 L13: 1.4888 L23: 0.2387 REMARK 3 S TENSOR REMARK 3 S11: -0.2049 S12: -0.5444 S13: 0.4636 REMARK 3 S21: 0.2185 S22: -0.1279 S23: 0.0319 REMARK 3 S31: 0.0656 S32: -0.5497 S33: 0.3327 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|597 - A|662 } REMARK 3 ORIGIN FOR THE GROUP (A): 6.7604 -18.0803 -18.9649 REMARK 3 T TENSOR REMARK 3 T11: 0.1638 T22: 0.3890 REMARK 3 T33: 0.1338 T12: 0.0816 REMARK 3 T13: -0.1029 T23: -0.0580 REMARK 3 L TENSOR REMARK 3 L11: 5.1879 L22: 1.5934 REMARK 3 L33: 3.4590 L12: 1.9575 REMARK 3 L13: -1.5902 L23: -0.3414 REMARK 3 S TENSOR REMARK 3 S11: -0.0853 S12: -0.5806 S13: 0.1334 REMARK 3 S21: 0.2910 S22: -0.0261 S23: -0.1383 REMARK 3 S31: 0.0129 S32: 0.1781 S33: 0.1114 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { A|663 - A|794 } REMARK 3 ORIGIN FOR THE GROUP (A): 13.4285 -8.4019 -30.8331 REMARK 3 T TENSOR REMARK 3 T11: 0.2364 T22: 0.4938 REMARK 3 T33: 0.4715 T12: -0.0296 REMARK 3 T13: -0.0069 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 1.9015 L22: 3.8933 REMARK 3 L33: 2.8579 L12: -1.8581 REMARK 3 L13: 0.6620 L23: 0.4812 REMARK 3 S TENSOR REMARK 3 S11: 0.0602 S12: 0.1564 S13: 0.7160 REMARK 3 S21: -0.1370 S22: -0.0353 S23: -0.5501 REMARK 3 S31: -0.3627 S32: 0.2715 S33: -0.0249 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C4I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058239. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JUL-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9173 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12262 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 39.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.82000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4BI1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30-35% AQUEOUS PEG300 ONLY, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.88500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.61000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.12500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.88500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.61000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.12500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.88500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 52.61000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.12500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.88500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 52.61000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.12500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 PHE A 515 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 GLN A 683 REMARK 465 VAL A 684 REMARK 465 GLY A 685 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 THR A 795 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 516 CG CD OE1 NE2 REMARK 470 ARG A 523 CD NE CZ NH1 NH2 REMARK 470 LYS A 529 CG CD CE NZ REMARK 470 SER A 533 OG REMARK 470 LYS A 538 CE NZ REMARK 470 GLU A 545 CG CD OE1 OE2 REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 CG CD CE NZ REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 LYS A 615 CG CD CE NZ REMARK 470 LYS A 616 CG CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 SER A 618 OG REMARK 470 LYS A 629 CG CD CE NZ REMARK 470 LYS A 649 CE NZ REMARK 470 ASN A 669 CG OD1 ND2 REMARK 470 GLN A 670 CG CD OE1 NE2 REMARK 470 MET A 671 CG SD CE REMARK 470 LYS A 696 CG CD CE NZ REMARK 470 ILE A 711 CG1 CG2 CD1 REMARK 470 LYS A 731 CG CD CE NZ REMARK 470 GLN A 736 CD OE1 NE2 REMARK 470 ILE A 738 CG1 CG2 CD1 REMARK 470 GLU A 753 CG CD OE1 OE2 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 ASP A 758 CG OD1 OD2 REMARK 470 LYS A 762 CG CD CE NZ REMARK 470 GLN A 765 CG CD OE1 NE2 REMARK 470 LYS A 769 CG CD CE NZ REMARK 470 LYS A 773 CD CE NZ REMARK 470 LYS A 777 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 646 -8.53 79.16 REMARK 500 GLN A 670 8.89 84.52 REMARK 500 LEU A 772 44.65 -93.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 7PE A 1796 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X20 A 1795 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PE A 1796 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C4E RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4F RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4G RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4H RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4J RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE INCLUDING HEXAHISTIDINE TAG IS AS DESCRIBED REMARK 999 IN NAT. CHEM. BIOL. 2010, 6, 259-368. DBREF 4C4I A 519 808 UNP P33981 TTK_HUMAN 519 808 SEQADV 4C4I MET A 496 UNP P33981 EXPRESSION TAG SEQADV 4C4I HIS A 497 UNP P33981 EXPRESSION TAG SEQADV 4C4I HIS A 498 UNP P33981 EXPRESSION TAG SEQADV 4C4I HIS A 499 UNP P33981 EXPRESSION TAG SEQADV 4C4I HIS A 500 UNP P33981 EXPRESSION TAG SEQADV 4C4I HIS A 501 UNP P33981 EXPRESSION TAG SEQADV 4C4I HIS A 502 UNP P33981 EXPRESSION TAG SEQADV 4C4I SER A 503 UNP P33981 EXPRESSION TAG SEQADV 4C4I SER A 504 UNP P33981 EXPRESSION TAG SEQADV 4C4I GLY A 505 UNP P33981 EXPRESSION TAG SEQADV 4C4I VAL A 506 UNP P33981 EXPRESSION TAG SEQADV 4C4I ASP A 507 UNP P33981 EXPRESSION TAG SEQADV 4C4I LEU A 508 UNP P33981 EXPRESSION TAG SEQADV 4C4I GLY A 509 UNP P33981 EXPRESSION TAG SEQADV 4C4I THR A 510 UNP P33981 EXPRESSION TAG SEQADV 4C4I GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 4C4I ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 4C4I LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 4C4I TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 4C4I PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 4C4I GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 4C4I SER A 517 UNP P33981 EXPRESSION TAG SEQADV 4C4I MET A 518 UNP P33981 EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY THR VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU HET X20 A1795 34 HET 7PE A1796 7 HETNAM X20 TERT-BUTYL 6-{[2-CHLORO-4-(DIMETHYLCARBAMOYL) HETNAM 2 X20 PHENYL]AMINO}-2-(1,3-OXAZOL-5-YL)-1H-PYRROLO[3,2- HETNAM 3 X20 C]PYRIDINE-1-CARBOXYLATE HETNAM 7PE 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY) HETNAM 2 7PE ETHOXY)ETHANOL HETSYN 7PE POLYETHYLENE GLYCOL FRAGMENT FORMUL 2 X20 C24 H24 CL N5 O4 FORMUL 3 7PE C14 H30 O7 FORMUL 4 HOH *(H2 O) HELIX 1 1 ASP A 561 LEU A 578 1 18 HELIX 2 2 GLN A 579 HIS A 581 5 3 HELIX 3 3 LEU A 609 LYS A 616 1 8 HELIX 4 4 ASP A 620 HIS A 641 1 22 HELIX 5 5 LYS A 649 ALA A 651 5 3 HELIX 6 6 PRO A 691 MET A 698 1 8 HELIX 7 7 SER A 712 GLY A 730 1 19 HELIX 8 8 ASN A 739 ASP A 749 1 11 HELIX 9 9 GLU A 761 LEU A 772 1 12 HELIX 10 10 SER A 781 LEU A 786 1 6 HELIX 11 11 HIS A 788 ILE A 793 1 6 SHEET 1 AA 6 SER A 517 VAL A 520 0 SHEET 2 AA 6 ARG A 523 SER A 533 -1 O ARG A 523 N VAL A 520 SHEET 3 AA 6 SER A 537 LEU A 543 -1 O VAL A 539 N ILE A 531 SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555 SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AB 3 ILE A 607 ASP A 608 0 SHEET 2 AB 3 PHE A 653 VAL A 656 -1 N ILE A 655 O ILE A 607 SHEET 3 AB 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 SITE 1 AC1 15 ILE A 531 VAL A 539 GLN A 541 ALA A 551 SITE 2 AC1 15 LYS A 553 ILE A 586 MET A 602 GLU A 603 SITE 3 AC1 15 CYS A 604 GLY A 605 ILE A 607 ASP A 608 SITE 4 AC1 15 SER A 611 LEU A 654 ILE A 663 SITE 1 AC2 5 SER A 537 LYS A 553 VAL A 555 TYR A 568 SITE 2 AC2 5 MET A 600 CRYST1 69.770 105.220 112.250 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014333 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009504 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008909 0.00000